George W. Lloyd - Jun 2, 2023 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role
EVP, Investments & CLO
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for George W. Lloyd
Stock symbol
RPRX
Transactions as of
Jun 2, 2023
Transactions value $
-$6,478,587
Form type
4
Date filed
6/6/2023, 05:07 PM
Previous filing
Mar 30, 2023
Next filing
Aug 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPRX Class A Ordinary Shares Sale -$3.1M -92.2K -43.46% $33.65 120K Jun 2, 2023 By GWL 2014 G, LLC F1
transaction RPRX Class A Ordinary Shares Sale -$56.5K -1.69K -1.3% $33.54 128K Jun 2, 2023 By GWL 2020 G, LLC F2
transaction RPRX Class A Ordinary Shares Sale -$644K -19.2K -14.97% $33.54 109K Jun 5, 2023 By GWL 2020 G, LLC F3
transaction RPRX Class A Ordinary Shares Sale -$2.67M -79.1K -72.5% $33.82 30K Jun 6, 2023 By GWL 2020 G, LLC F4
holding RPRX Class A Ordinary Shares 496K Jun 2, 2023 By GWL 2013 NG, LLC
holding RPRX Class A Ordinary Shares 274K Jun 2, 2023 By IRA
holding RPRX Class A Ordinary Shares 3K Jun 2, 2023 Direct
holding RPRX Class A Ordinary Shares 4.01K Jun 2, 2023 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.51 to $33.80 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.53 to $33.55 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.50 to $33.69 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.50 to $34.02 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.